What Is a TaqMan Array Card and How Does It Work?

A TaqMan Array Card is a microfluidic card about the size of a large playing card that runs up to 384 real-time PCR reactions at once, letting researchers screen a single sample for dozens of pathogens in a few hours rather than days. Developed by Applied Biosystems (now part of Thermo Fisher Scientific), the card has become a workhorse in infectious disease surveillance, outbreak investigation, and environmental monitoring, where the question is rarely “does this patient have pathogen X?” but rather “which of these 30 possible pathogens is causing this illness?” That shift from testing one target at a time to testing many simultaneously is what makes the platform valuable, and it is also what introduces tradeoffs in sensitivity that any user needs to understand.

What the Card Actually Is

A TaqMan Array Card (often shortened to TAC) is a flat, credit-card-shaped piece of plastic with a network of tiny channels etched into it. Each channel leads to individual reaction wells that have been pre-loaded with dried-down primers and probes for specific genetic targets. You load your sample mixed with a PCR master mix into one of the card’s fill ports, centrifuge the card so liquid distributes into all the wells, seal it, and place it on a real-time PCR instrument. The card can support one to eight samples at a time, with anywhere from about 11 to 380 different assay targets per configuration, run in up to four replicates each.1ScienceDirect. Chapter 5 – TaqMan low-density arrays for simultaneous detection of multiple pathogens The “TaqMan” part of the name refers to the chemistry: each well contains a hydrolysis probe that gets cleaved during PCR amplification, releasing a fluorescent signal that the instrument reads in real time.

The practical appeal is straightforward. Instead of setting up dozens of individual PCR tubes, pipetting reagents for each target, and running multiple plates, a technician loads one card and gets results for all targets simultaneously. The dried reagents also reduce pipetting errors and simplify quality control. A full run, from loading sample to reading results, takes roughly two to three hours.

How Sensitive Is It Compared to Standard PCR

This is the question that comes up in almost every validation study, and the honest answer is that TAC is slightly less sensitive than running each assay individually, but the gap is often small enough that it does not matter for most surveillance purposes.

When researchers tested the card against singleplex PCR (one target per reaction tube) using known amounts of bacterial DNA, the individual reactions outperformed the card at very low concentrations. At moderate concentrations, though, the card detected all agents when replicate wells were used. At lower concentrations, detection rates varied by organism: some targets were picked up reliably while others dropped to roughly half the time.2PLoS ONE. The Potential of TaqMan Array Cards for Detection of Multiple Biological Agents by Real-Time PCR The underlying reason is volume: each well on the card holds a smaller reaction volume than a standard PCR tube, so there is simply less template DNA to amplify. One methods paper put the difference plainly, noting that TAC is roughly tenfold less sensitive than an equivalent individual PCR assay.3MethodsX. Simultaneous detection of multiple pathogens with the TaqMan Array Card

In clinical practice, this sensitivity gap often narrows because pathogen loads in actual patient samples tend to be higher than the trace quantities used in analytical limit-of-detection experiments. A study evaluating TAC against standard real-time PCR for 21 pathogens causing acute undifferentiated febrile illness found overall sensitivity of about 96% and specificity of about 88%, with an overall accuracy around 93%.4PubMed Central. Performance evaluation of TaqMan Array Card real-time PCR for multi-pathogen detection in acute undifferentiated febrile illness A respiratory pathogen study using over 750 clinical throat swabs reported sensitivity and specificity above 95%.5PubMed Central. Evaluation of TaqMan Array card (TAC) for the detection of 28 respiratory pathogens So while the card will occasionally miss a very-low-level infection that a dedicated singleplex assay would catch, its performance on real specimens is strong enough for most diagnostic and surveillance applications.

Where TAC Has Been Used in Infectious Disease Surveillance

The platform’s flexibility lies in the fact that you choose which assays go on the card. A lab studying diarrheal disease designs one card; a team investigating unexplained fevers designs another. This customizability has led to TAC deployments across a wide range of disease categories, including gastrointestinal illness, respiratory infections, febrile illness, meningitis, sepsis, and even drug-resistance screening for tuberculosis, malaria, and resistant bacteria.6MethodsX. Simultaneous detection of multiple pathogens with the TaqMan Array Card

Diarrheal Disease

Some of the earliest and most influential TAC work focused on enteric pathogens. A card targeting 19 enteropathogens was developed for both clinical diagnosis and surveillance of diarrheal disease, and validation showed it could provide fast, accurate, and quantitative detection across a broad spectrum of gut pathogens.7PubMed Central. A laboratory-developed TaqMan Array Card for simultaneous detection of 19 enteropathogens Crucially, because TAC provides a cycle-threshold value for each target (essentially a proxy for how much pathogen is present), researchers can go beyond simply detecting a bug and start asking whether the quantity of that bug is linked to actual disease. In a study of infants in Tanzania, qualitative detection alone (just asking “is the pathogen there?”) did not distinguish diarrhea cases from healthy controls, because many healthy children also carried the same organisms. But when pathogen quantity was factored in, rotavirus, astrovirus, and Shigella showed clear dose-dependent associations with diarrhea, and high loads of certain other organisms predicted poor growth over the following months.8PubMed Central. Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case-control study That kind of quantitative nuance is difficult to get from conventional culture-based methods.

Acute Febrile Illness

Fever without an obvious cause is one of the most common reasons for hospital admission in tropical regions, and identifying the responsible pathogen is notoriously difficult when dozens of bacteria, viruses, and parasites are candidates. TAC cards designed for acute febrile illness have been deployed extensively. One card targeting 26 organisms, including Ebola virus, demonstrated an overall sensitivity of about 88% and specificity of 99% when tested on over a thousand blood samples.9PubMed Central. Development of a TaqMan Array Card for Acute-Febrile-Illness Outbreak Investigation and Surveillance of Emerging Pathogens, Including Ebola Virus In northern Tanzania, a febrile illness TAC panel nearly doubled the diagnostic yield compared to conventional testing methods, bumping identification rates from about 10% to nearly 18% of enrolled patients. It turned up infections that standard workups had missed entirely, including Rift Valley Fever virus, Bartonella, Brucella, and Rickettsia.10PubMed Central. TaqMan Array Card real-time polymerase chain reaction panel to detect pathogens in whole blood of febrile inpatients in northern Tanzania, 2016-2019

In a separate study focused on patients suspected of viral hemorrhagic fever in an African setting, TAC detected pathogens in about a third of samples. The dominant finding was malaria parasites, but the card also picked up Salmonella, Yellow Fever virus, Leptospira, and Rickettsia, organisms that would require completely different treatments.11PubMed Central. Utility of TaqMan Array Cards for detection of acute febrile illness etiologies in patients suspected of viral hemorrhagic fever infections For clinicians working in resource-limited settings where ordering individual tests for each suspect pathogen is neither practical nor affordable, this kind of broad screening is transformative.

Respiratory Infections

Respiratory TAC panels have been validated for simultaneous detection of more than 20 viral and bacterial respiratory targets. A multicenter evaluation tested one such card on the Applied Biosystems ViiA 7 instrument across multiple labs, confirming consistent performance.12PubMed Central. Comparative analytical evaluation of the respiratory TaqMan Array Card with real-time PCR and commercial multi-pathogen assays During the COVID-19 pandemic, the appeal of running a respiratory panel rather than a SARS-CoV-2-only test became especially clear: a single card could rule in or rule out influenza, RSV, adenovirus, and other common respiratory viruses alongside the novel coronavirus.

How TAC Compares to Other Multiplex Platforms

TAC is not the only game in town for multiplex pathogen detection. Commercial platforms like the BioFire FilmArray and the Luminex Gastrointestinal Pathogen Panel (GPP) offer similar multi-target screening in sealed cartridges. A head-to-head comparison of three gastrointestinal panels found that the FilmArray detected a virus in about 96% of known-positive samples, TAC in about 83%, and GPP in about 79%. Overall clinical accuracy was similar across all three, ranging from about 97% to 98%. But performance varied sharply by target: all three platforms caught rotavirus with high sensitivity, while adenovirus detection was notably weaker on GPP and TAC than on FilmArray.13PubMed Central. Comparison of three multiplex gastrointestinal platforms for the detection of gastroenteritis viruses

The key differences between TAC and these commercial cartridges are customizability and cost structure. Closed cartridge systems come pre-loaded and ready to use, which is convenient for clinical labs that need fast turnaround with minimal hands-on time. But you are locked into whatever targets the manufacturer chose. TAC cards, by contrast, can be custom-designed: you pick the assays, decide how many replicates each target gets, and can update the card layout when new pathogens emerge. The trade-off is that TAC requires more technical expertise, more sample preparation, and access to a compatible real-time PCR instrument, which makes it better suited to reference laboratories and research settings than to point-of-care use.

Outbreak Investigation in the Field

One of the most compelling use cases for TAC is outbreak response, where you need to screen for many possible causes quickly and cannot afford to wait for culture results or sequential testing. In Tanzania, a custom 31-target TAC card was deployed during outbreaks of acute febrile illness between 2015 and 2017. Epidemiologists collected specimens in the field, shipped them to a central national lab, and had TAC results within two days. The approach diagnosed a typhoid outbreak and simultaneously ruled out dozens of other possible causes.14PubMed Central. Use of TaqMan Array Cards to Screen Outbreak Specimens for Causes of Febrile Illness in Tanzania That speed matters in outbreak settings, where misidentifying the cause delays public health interventions and allows further spread.

The card’s inclusion of high-consequence pathogens like Ebola virus on some configurations also means that a single test can screen for bioterrorism agents or emerging viruses alongside more mundane causes of fever, without requiring separate biosafety-level-specific assays for each one.

Beyond Human Diagnostics

TAC has expanded well beyond clinical medicine. The same principle of screening many targets at once applies wherever you have a complex sample and a long list of possible organisms.

Environmental and Wastewater Surveillance

Researchers have adapted TAC for wastewater-based epidemiology, designing a 35-target card covering bacteria, viruses, protozoa, and helminths and applying it to concentrated wastewater samples from treatment plants in Atlanta during 2020.15PubMed Central. Simultaneous detection and quantification of multiple pathogen targets in wastewater The idea is that community-level disease trends show up in sewage before clinical case counts rise, and a multiplex card can track many pathogens at once rather than requiring separate assays for each one. In Bangladesh, TAC was used to screen wastewater and soil samples, detecting a wide array of enteric pathogens including Shigella, Campylobacter, Vibrio cholerae, rotavirus, and parasites like Trichuris and Ancylostoma. Most wastewater samples carried multiple pathogens simultaneously.16Bangladesh Journal of Zoology. Detection of pathogens in waste water and soil by Taqman Array Card (TAC) system

A detailed comparison of TAC against standard quantitative PCR for enteric pathogen detection across diverse sample types, including human stool, animal feces, water, and soil, found that about 89% of results agreed between the two methods. TAC showed slightly lower sensitivity than standard PCR but achieved perfect specificity in one experiment, meaning it rarely called something positive when it was not. Interestingly, in about 4% of cases TAC detected a pathogen that standard PCR missed, suggesting the two methods can be complementary rather than strictly hierarchical.17The Lancet Planetary Health. Comparison of standard quantitative PCR and TaqMan array card for detection of enteric pathogens across diverse human, animal, and environmental reservoirs

Wildlife and Zoonotic Disease

A recent study applied TAC for the first time to wildlife disease surveillance, screening Korean water deer for multiple zoonotic pathogens in a single high-throughput run.18One Health. Expanding the wildlife reservoir landscape: A high-throughput molecular surveillance study of zoonotic pathogens in Korean water deer A parallel effort screened wild micromammals (rodents and shrews) across the Republic of Korea for 45 viral, bacterial, and protozoan pathogens, producing baseline data on the distribution of zoonotic agents carried by these animals.19Parasites & Vectors. Broad-spectrum molecular detection of zoonotic agents in wild micromammals: a nationwide surveillance study in the Republic of Korea Wildlife surveillance is a setting where TAC’s strengths, broad screening with limited sample volume, really shine. You typically have one tissue sample from a captured or deceased animal and want to know what it is carrying. Running 45 individual assays would be impractical; running one card is not.

Antimicrobial Resistance Gene Detection

A newer application repurposes the TAC platform to screen not for pathogens themselves but for the genetic markers of drug resistance. One team developed a custom card capable of detecting 23 antimicrobial resistance genes directly from clinical samples of critically ill children, bypassing the need to first grow the organism in culture, which can take days.20PubMed Central. Rapid Detection of Antimicrobial Resistance Genes in Critically Ill Children Using a Custom TaqMan Array Card In an ICU setting where antibiotic choices need to be made quickly and resistance patterns shift constantly, getting resistance gene information in hours rather than days could meaningfully affect treatment decisions.

Gene Expression and MicroRNA Profiling

The TAC platform is not limited to pathogen detection. A closely related product line, TaqMan Array Human MicroRNA Cards, uses the same microfluidic format to profile hundreds of small RNA molecules in a single run. Researchers have used these cards to study microRNA expression in respiratory cells affected by invasive Candida infection21PLoS ONE. MicroRNA Expression Profiling of Human Respiratory Epithelium Affected by Invasive Candida Infection and to compare microRNA profiles in immune cells from HIV-1-infected individuals who naturally control the virus versus those who do not.22PLoS ONE. Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors Custom gene expression cards have also been used to profile host responses to dengue virus infection across cell lines and patient samples.23PLoS Neglected Tropical Diseases. Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients In these applications, the card is not hunting for pathogens but measuring how the host’s own genes respond to infection, providing a different kind of diagnostic or research insight.

Practical Limitations Worth Knowing

TAC is a powerful tool, but it has real constraints that shape where and how it gets used.

The sensitivity gap with standard singleplex PCR, roughly tenfold, means that very-low-level infections can be missed.24MethodsX. Simultaneous detection of multiple pathogens with the TaqMan Array Card In a validation study testing known clinical samples, the card correctly identified 19 out of 20, missing one sample that had a very low pathogen concentration at the edge of detectability. At the lowest standard concentration tested (around 7 copies per microliter of DNA), the card detected the target about 90% of the time, with some assays performing more consistently than others. This is a tradeoff inherent to the miniaturized format: smaller reaction volumes mean fewer template molecules per well. For high-consequence pathogens where even a trace-level detection matters, a negative TAC result on a suspect sample warrants follow-up with a dedicated singleplex assay.

The limit of detection varies by card design and target. One pneumococcal serotyping card achieved a detection limit of roughly 20 to 200 femtograms of DNA per reaction, equivalent to somewhere around 8 to 84 bacterial genome copies.25PubMed Central. Development of a TaqMan Array Card for Pneumococcal Serotyping on Isolates and Nasopharyngeal Samples Other cards report limits between 10 and 100 copies per microliter for plasmid controls.26PubMed Central. Performance evaluation of TaqMan Array Card real-time PCR for multi-pathogen detection in acute undifferentiated febrile illness These are respectable numbers but not at the bleeding edge of what molecular diagnostics can achieve when all the reagent optimization is focused on a single target.

Sample preparation upstream of the card also matters. Different specimen types (whole blood, stool, tissue, wastewater) require different extraction protocols, and the quality of the extracted nucleic acid directly affects card performance. For blood samples, some teams use enzymatic pre-treatment with lysis enzymes before automated extraction to break open bacterial cells that might otherwise resist standard lysis.27PLoS ONE. Optimization of Multiple Pathogen Detection Using the TaqMan Array Card: Application for a Population-Based Study of Neonatal Infection Getting the extraction right is not trivial and requires trained personnel, which is one reason TAC tends to live in reference labs rather than frontline clinics.

Finally, the cards are single-use and must be custom-manufactured for each assay configuration. Ordering a new card layout requires lead time for design, production, and validation. This is not something you can reconfigure overnight when a new pathogen emerges, though labs that already have validated cards can run them on short notice, as the Tanzanian outbreak response demonstrated. The per-card cost is substantially lower than running the same number of individual assays, but the upfront investment in designing, ordering, and validating a custom card layout is not insignificant. For laboratories that only occasionally need multiplex screening, a commercial closed-cartridge system with pre-designed panels may be more practical despite the loss of customizability.